PRTK Annual Shareholders Equity
-$171.04 M
-$43.26 M-33.85%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual stockholders equity is -$171.04 million, with the most recent change of -$43.26 million (-33.85%) on December 31, 2022. During the last 3 years, it has fallen by -$131.40 million (-331.41%).PRTK Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Shareholders Equity
-$201.37 M
-$12.33 M-6.52%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly stockholders equity is -$201.37 million, with the most recent change of -$12.33 million (-6.52%) on June 30, 2023. Over the past year, it has dropped by -$52.00 million (-34.81%).PRTK Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.9% | -34.8% |
| 3 y3 years | -331.4% | -217.3% |
| 5 y5 years | -307.4% | -335.5% |
PRTK Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -268.9% | -242.8% |
Paratek Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$201.37 M(+6.5%) |
| Mar 2023 | - | -$189.04 M(+10.5%) |
| Dec 2022 | -$171.04 M(+33.8%) | -$171.04 M(+2.9%) |
| Sept 2022 | - | -$166.15 M(+11.2%) |
| June 2022 | - | -$149.37 M(+6.5%) |
| Mar 2022 | - | -$140.30 M(+9.8%) |
| Dec 2021 | -$127.79 M(+25.0%) | -$127.79 M(+21.7%) |
| Sept 2021 | - | -$104.99 M(+5.7%) |
| June 2021 | - | -$99.29 M(-16.6%) |
| Mar 2021 | - | -$119.01 M(+16.4%) |
| Dec 2020 | -$102.26 M(+157.9%) | -$102.26 M(+28.0%) |
| Sept 2020 | - | -$79.88 M(+25.9%) |
| June 2020 | - | -$63.46 M(+14.9%) |
| Mar 2020 | - | -$55.24 M(+39.3%) |
| Dec 2019 | -$39.65 M(-183.3%) | -$39.65 M(-2.4%) |
| Sept 2019 | - | -$40.61 M(+196.9%) |
| June 2019 | - | -$13.68 M(-185.3%) |
| Mar 2019 | - | $16.03 M(-66.3%) |
| Dec 2018 | $47.58 M(-42.3%) | $47.58 M(-17.4%) |
| Sept 2018 | - | $57.63 M(-32.6%) |
| June 2018 | - | $85.49 M(-22.8%) |
| Mar 2018 | - | $110.77 M(+34.3%) |
| Dec 2017 | $82.48 M(+15.2%) | $82.48 M(-17.4%) |
| Sept 2017 | - | $99.87 M(-11.9%) |
| June 2017 | - | $113.38 M(+33.7%) |
| Mar 2017 | - | $84.81 M(+18.5%) |
| Dec 2016 | $71.59 M(-29.3%) | $71.59 M(-16.2%) |
| Sept 2016 | - | $85.47 M(-19.7%) |
| June 2016 | - | $106.46 M(+45.6%) |
| Mar 2016 | - | $73.14 M(-27.8%) |
| Dec 2015 | $101.24 M(+6.3%) | $101.24 M(-15.8%) |
| Sept 2015 | - | $120.22 M(-14.7%) |
| June 2015 | - | $140.99 M(+66.2%) |
| Mar 2015 | - | $84.85 M(-10.9%) |
| Dec 2014 | $95.22 M | $95.22 M(+178.3%) |
| Sept 2014 | - | $34.21 M(-18.3%) |
| June 2014 | - | $41.87 M(-39.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $69.45 M(-3.2%) |
| Dec 2013 | $71.74 M(-24.8%) | $71.74 M(-6.0%) |
| Sept 2013 | - | $76.29 M(-4.6%) |
| June 2013 | - | $79.94 M(-7.0%) |
| Mar 2013 | - | $85.92 M(-9.9%) |
| Dec 2012 | $95.39 M(+45.1%) | $95.39 M(-5.5%) |
| Sept 2012 | - | $100.98 M(+5.9%) |
| June 2012 | - | $95.31 M(+53.8%) |
| Mar 2012 | - | $61.96 M(-5.8%) |
| Dec 2011 | $65.75 M(+3.0%) | $65.75 M(+15.3%) |
| Sept 2011 | - | $57.01 M(-7.0%) |
| June 2011 | - | $61.30 M(-2.2%) |
| Mar 2011 | - | $62.66 M(-1.8%) |
| Dec 2010 | $63.81 M(-10.2%) | $63.81 M(-3.2%) |
| Sept 2010 | - | $65.92 M(-3.3%) |
| June 2010 | - | $68.18 M(-2.1%) |
| Mar 2010 | - | $69.67 M(-2.0%) |
| Dec 2009 | $71.07 M(-211.8%) | $71.07 M(-2.7%) |
| Sept 2009 | - | $73.03 M(-3.9%) |
| June 2009 | - | $75.97 M(-8.1%) |
| Mar 2009 | - | $82.70 M(-230.1%) |
| Dec 2008 | -$63.58 M(-239.0%) | -$63.58 M(-173.0%) |
| Sept 2008 | - | $87.11 M(-6.6%) |
| June 2008 | - | $93.31 M(+103.7%) |
| Mar 2008 | - | $45.80 M(+0.1%) |
| Dec 2007 | $45.75 M(-23.5%) | $45.75 M(-1.8%) |
| Sept 2007 | - | $46.59 M(+28.0%) |
| June 2007 | - | $36.40 M(-27.5%) |
| Mar 2007 | - | $50.23 M(-16.0%) |
| Dec 2006 | $59.82 M(-199.0%) | $59.82 M(-10.4%) |
| Sept 2006 | - | $66.74 M(-8.8%) |
| June 2006 | - | $73.15 M(-208.4%) |
| Mar 2006 | - | -$67.49 M(+11.7%) |
| Dec 2005 | -$60.44 M(+60.7%) | -$60.44 M(+60.7%) |
| Dec 2004 | -$37.61 M(+439.5%) | -$37.61 M |
| Dec 2002 | -$6.97 M(+377.9%) | - |
| Dec 2001 | -$1.46 M | - |
FAQ
- What is Paratek Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual shareholders equity year-on-year change?
- What is Paratek Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Paratek Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of PRTK is -$171.04 M
What is the all time high annual shareholders equity for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual stockholders equity is $101.24 M
What is Paratek Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, PRTK annual stockholders equity has changed by -$43.26 M (-33.85%)
What is Paratek Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of PRTK is -$201.37 M
What is the all time high quarterly shareholders equity for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly stockholders equity is $140.99 M
What is Paratek Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, PRTK quarterly stockholders equity has changed by -$52.00 M (-34.81%)